J.R. Landry became one of only a handful in the nation, and the first in Rhode Island, to get what doctors believe will be ...

A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Blood Cell Factors Market Insights. The Blood Cell Factors industry is experiencing robust expansion driven by rising ...

The Ministry of Health and the government at large are being urged to increase investment in the treatment and care of people living with hemophilia, a lifelong blood disorder that impairs ...

It was found that those with severe hemophilia B have less than 1% of normal factor IX activity, often experiencing spontaneous bleeding that can cause joint damage or life-threatening events.

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

Columnist G Shellye Horowitz says that understanding which hemophilia treatments don't work in her body is as critical as ...